Dilated cardiomyopathy caused by a coronary-pulmonary fistula treated successfully with coil embolization

Hangyuan Guo1, Bingquan You, Jong-Dae Lee

  • 1Department of Cardiology, Shaoxing People's Hospital, The First Affiliated Hospital of Medical College, Shaoxing University, Shaoxing, China. ghangyuan@hotmail.com

Insights

A rare cause of dilated cardiomyopathy (DCM) in adults with normal coronary arteries, a coronary-pulmonary fistula leading to myocardial ischemia, was successfully treated. Percutaneous coil embolization offers a low-risk alternative to surgery for this condition.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Coronary artery anomalies, such as fistulae, are uncommon but can lead to myocardial ischemia.
  • The coronary steal phenomenon can exacerbate ischemia in patients with coronary artery anomalies.

Observation:

  • A case of DCM was identified in an adult with normal coronary arteries.
  • The DCM was attributed to a coronary-pulmonary fistula causing myocardial ischemia via the coronary steal phenomenon.
  • The patient's condition was successfully managed without surgical intervention.

Findings:

  • Percutaneous coil embolization effectively treated the coronary-pulmonary fistula.
  • This intervention resolved the myocardial ischemia and improved the DCM.
  • The coronary steal phenomenon was mitigated by occluding the fistula.

Implications:

  • Coronary fistulae and associated coronary steal are rare but treatable causes of DCM.
  • Percutaneous treatment is a viable, low-risk alternative to surgery for such cases.
  • Clinical and anatomical factors should guide the choice between percutaneous and surgical interventions.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...